| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/20/1994 | EP0593065A1 Recombinant fibroblast growth factors |
| 04/20/1994 | EP0592949A2 N-(aminocarbonyl)-piperidines/pepirazines as aggregation inhibiting agents |
| 04/20/1994 | EP0592903A2 Use of ancrod for the preparation of drugs for the treatment of restenosis |
| 04/20/1994 | EP0592791A2 Tricyclic compounds and peptide derivatives thereof |
| 04/20/1994 | EP0592529A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
| 04/20/1994 | EP0293394B1 Novel thrombolytic proteins |
| 04/20/1994 | CN1085557A Enatiomeric hydroxylated xanthine compounds |
| 04/19/1994 | US5304638 Protein separation medium |
| 04/19/1994 | US5304482 Genetic engineering |
| 04/19/1994 | US5304383 Pharmaceutical preparation based on Lys-plasminogen |
| 04/19/1994 | US5304372 From blood |
| 04/19/1994 | US5304325 Emulsions of fluorochemical, water, surfactant; synthetic blood |
| 04/19/1994 | CA1328606C Use of metformine in the preparation of drugs |
| 04/19/1994 | CA1328602C Hemoglobin macromolecular conjugates, their preparation process and their uses |
| 04/14/1994 | WO1994007918A1 Multimeric polyvalent antithrombotic agents |
| 04/14/1994 | WO1994007830A1 A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 04/14/1994 | WO1994007537A1 Pharmaceutical composition for site-specific release of a clot-dissolving protein |
| 04/14/1994 | WO1994007528A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor viia-tissue factor complex |
| 04/14/1994 | WO1994007366A1 Pp14-based therapy |
| 04/14/1994 | DE4234130A1 Phospholipase A¶2¶ inhibierende Phosphatidylcholinverbindungen Phospholipase inhibitory A¶2¶ Phosphatidylcholinverbindungen |
| 04/14/1994 | CA2146324A1 Pharmaceutical composition for the site-specific release of clot-dissolving protein and method for the preparation thereof |
| 04/14/1994 | CA2145847A1 Multimeric polyvalent antithrombotic agents |
| 04/14/1994 | CA2145762A1 Pp14-based therapy |
| 04/14/1994 | CA2145517A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor viia - tissue factor complex |
| 04/13/1994 | EP0592242A1 Fibrin sealant compositions and method for utilizing same |
| 04/13/1994 | EP0591765A2 1,4-Dihydropyridine-alkoxy and alkylamino esters as antihypertensives |
| 04/13/1994 | EP0591605A2 Method for suppressing coloring of human serum albumin |
| 04/13/1994 | EP0591492A1 A pharmaceutical composition containing a defined lipid system |
| 04/13/1994 | EP0591420A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 04/13/1994 | EP0591385A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591363A1 Pharmaceutical preparations containing torasemid |
| 04/13/1994 | EP0591355A1 Porphycene compounds for photodynamic therapy |
| 04/13/1994 | CA2108093A1 Carboxylic acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 04/12/1994 | US5302596 Tricyclic compounds as TXA2 antagonists |
| 04/12/1994 | US5302590 Compounds useful as dual antagonists of platelet activating factor and leukotriene D4 |
| 04/12/1994 | EP0614368A4 Safe human transfusion blood. |
| 04/12/1994 | CA1328540C Cyclic anticoagulant peptides |
| 04/09/1994 | CA2566574A1 Fibrin sealant compositions and method for utilizing same |
| 04/06/1994 | EP0590531A1 Antithrombin III preparation |
| 04/06/1994 | EP0590520A1 Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments |
| 04/06/1994 | EP0590132A1 $i(IN VITRO)-DERIVED HUMAN NEUTROPHIL PRECURSOR CELLS |
| 04/06/1994 | EP0590126A1 Polypeptides having kinase activity, their preparation and use |
| 04/06/1994 | EP0590092A1 Nitrosation of homocysteine as a method for treating homocysteinemia |
| 04/06/1994 | EP0590076A1 Production of human hemoglobin in transgenic pigs |
| 04/06/1994 | EP0489116B1 Fusion proteins comprising gm-csf and il-3 |
| 04/06/1994 | EP0383856B1 Use of peptides for inhibiting blood vessel blockage |
| 04/06/1994 | CN1084846A Ethanolamine derivatives |
| 04/06/1994 | CN1084844A Methods for manufacturing mixtures of higher alphathic alcohols for pharmaceutical compositions |
| 04/06/1994 | CA2107533A1 Dihydropyridine-alkoxy- and -alkylamino-aroyl esters |
| 04/05/1994 | USRE34580 Stirring suspension with addition of catalytic amount of modification I until rearrangement is complete |
| 04/05/1994 | US5300513 Vasopressin antagonists; vasodilators, hypotensive agents, water diuretics, and platelet agglutination inhibitors |
| 04/05/1994 | CA1328332C Peptide boronic acid inhibitors of trypsin-like proteases |
| 04/03/1994 | CA2107514A1 Acylsulfonamido- and sulfonamidopyridine-2-carboxylic acid esters and their pyridine n-oxides, processes for their preparation and their use as medicaments |
| 03/31/1994 | WO1994006761A1 Benzenealkanoic acids for cardiovascular diseases |
| 03/31/1994 | WO1994006457A1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 03/31/1994 | WO1994001547A3 A method for generation of antibodies to cell surface molecules |
| 03/30/1994 | EP0589741A1 Use of a direct inhibitor of thrombin for the production of a drug with thrombolytic activity |
| 03/30/1994 | EP0589181A2 Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| 03/30/1994 | CN1084408A Cyclic adhesion inhibitors |
| 03/29/1994 | US5298503 Cardiovascular |
| 03/23/1994 | EP0587754A1 Method for improving autologous transplantation |
| 03/23/1994 | EP0587610A1 Specifically beta-beta cross-linked hemoglobins and method of preparation |
| 03/23/1994 | EP0458939B1 STABILIZATION OF t-PA pro |
| 03/23/1994 | CN1084166A Substituted (benzothiazolyl-and quinoxalyl-methoxy) phenyl-acetic acid derivatives |
| 03/22/1994 | US5296494 Pyrrolidine compounds having thromboxane A2 receptor antagonistic activity and thromboxane A2 synthase inhibiting activity |
| 03/22/1994 | US5296490 Pharmaceutically useful pyrazolopyridines |
| 03/22/1994 | US5296467 Polypeptide salts |
| 03/22/1994 | US5296366 Method for the isolation and expression of a gene which codes for streptokinase, nucleotide sequence obtained, recombinant DNA and transformed microorgnaisms |
| 03/22/1994 | US5296223 Subtilisin as an oral thrombolytic agent |
| 03/22/1994 | CA1327936C Phospholipase a_ inhibiting compositions and their use |
| 03/17/1994 | WO1994005796A1 Long wap promoter for mammary expression of human protein c |
| 03/17/1994 | WO1994005696A1 Novel peptide, and antithrombotic agent, anticoagulant for extracorporeal circulation, cell fusion inhibitor, cancer metastasis inhibitor, protective for platelet preparation for transfusion and pack of platelet preparation for transfusion |
| 03/17/1994 | WO1994005694A1 Platelet aggregation inhibitors |
| 03/17/1994 | WO1994005692A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 03/17/1994 | WO1994005631A1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs |
| 03/17/1994 | WO1994005310A1 Peptide inhibitors of cellular adhesion |
| 03/17/1994 | WO1994005305A1 Digitalis-like compounds |
| 03/17/1994 | WO1994005290A1 Platelet aggregation inhibitor |
| 03/17/1994 | WO1994005286A1 Ready-to-inject azosemide solutions |
| 03/17/1994 | EP0585366A4 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood. |
| 03/17/1994 | CA2144333A1 Long wap promoter for mammary expression of human protein c |
| 03/17/1994 | CA2144180A1 Peptide inhibitors of cellular adhesion |
| 03/17/1994 | CA2122912A1 Novel peptides, and platelet aggregation-inhibiting agents, blood coagulation-inhibiting agents for extracorporeal circulation, cell adhesion-inhibiting agents, tumor metastasis inhibiting agents, agents for protecting platelet preparations for blood transfusion and platelet preparation packs for transfusion using said novel peptides |
| 03/16/1994 | EP0587134A2 Cyclic urea derivatives, medicaments containing them and process for their preparation |
| 03/16/1994 | EP0586537A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
| 03/16/1994 | EP0586381A1 Improved blood substitute |
| 03/15/1994 | US5294723 Antitumor, immunology |
| 03/15/1994 | US5294718 Piperidino-3,4-dihydrocarbostyril compounds |
| 03/15/1994 | US5294626 Arylsulphonamides pharmaceutical compositions containing these compounds |
| 03/15/1994 | US5294616 Fibrinogen receptor antagonists |
| 03/15/1994 | CA1327800C Derivatives of aza-2-bicyclooctane-3-carboxylic acid, processes for their preparation and pharmaceutical compositions containing them |
| 03/12/1994 | CA2105934A1 Cyclic urea derivatives |
| 03/09/1994 | EP0585939A2 TNF ligands |
| 03/09/1994 | EP0585504A1 Phospholipid dependant prothrombin activator and its use in lupus anticoagulant testing |
| 03/09/1994 | EP0585366A1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 03/09/1994 | EP0585296A1 2-(pyrrolidinyl-1-methyl)-piperidine derivatives and their use as kappa-recept or agonists |
| 03/09/1994 | EP0341300B1 Stimulation of stem cell growth by the bryostatins |
| 03/09/1994 | CN1083486A Heteroatoms-containing tricyclic compounds |
| 03/09/1994 | CN1083475A Chemical compounds |
| 03/09/1994 | CN1083473A Novel compounds |